跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
modified IL-18
首页
药物
modified IL-18
modified IL-18
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
US 2005147622 A1
申请人: US NAT INST HEALTH
优先权: 2000
US
3 件公开
US 2005220767 A1
申请人: COLLINS PETER L
优先权: 2004
US
MODIFIED IL-18 POLYPEPTIDES
US 2023357342 A1
申请人: BRIGHT PEAK THERAPEUTICS AG
优先权: 2022
CN
US
2 件公开
Immune antigen specific IL-18 immunocytokines and uses thereof
US 12383631 B2
申请人: BRIGHT PEAK THERAPEUTICS AG
优先权: 2022
CN
US
2 件公开
COMBINED COMPOSITION OF MODIFIED CYTOKINE AND CD40 AGONIST AND ANTI-TUMOR USE THEREOF
WO 2025031434 A1
申请人: LETO LABORATORIES CO LTD
优先权: 2023
CN
WO
2 件公开
IL-18 POLYPEPTIDES MODIFIED WITH POLYMERS
US 20250186594 A1
申请人: BRIGHT PEAK THERAPEUTICS AG
优先权: 2023
US
WO
2 件公开
TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES
US 20250186597 A1
申请人: BRIGHT PEAK THERAPEUTICS AG
优先权: 2023
US
WO
2 件公开
Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use
US 7067120 B2
申请人: SHANGHAI MEDIPHARM BIOTECH CO
优先权: 2001
US
2 件公开
SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES
US 2012107272 A1
申请人: MANOHARAN MUTHIAH
优先权: 2009
US
Modified IL-18 polypeptides and uses thereof
CN 116368148 A
申请人: MINFOUND THERAPEUTICS AG
优先权: 2020
CN
RNA (Ribonucleic Acid) composition for amplifying NK (Natural Killer) cells and genetically modified NK cell medicinal preparation based on RNA composition
CN 117701578 A
申请人: JIANGSU PURECELL BIOMEDICAL TECH CO LTD
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈